This page shows the latest Nature Medicine news and features for those working in and with pharma, biotech and healthcare.
Final results from Novartis’ phase 3 SPR1NT trial assessing Zolgensma (onasemnogene abeparvovec) have been published in Nature Medicine.
In June, a study published in Nature Medicine showed that gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of Alzheimer’s disease.
Nature’s lessons. So, forgive the Darwinian diversion but I think we can learn business lessons from biological tragedies. ... This column is also available as a podcast on spotify, or search your podcast provider for ‘Darwin’s Medicine’.
A new study, published in Nature Medicine, has showed that Roche’s investigational candidate gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of ... At the time, despite the disappointing results, analysis
with the therapy in the journal Nature Medicine last year.
The multiple departures and the timing of Bosley’s departure has inevitably raised eyebrows, It comes just after Editas announced new preclinical data had been published in the journal Nature Medicine ... on EDIT-101, the biotech’s lead CRISPR
More from news
Approximately 1 fully matching, plus 29 partially matching documents found.
The egalitarian nature of the nationalised service places great weight on establishing how new innovations can meet the needs of every patient, while ensuring precision medicine is free at the point ... Now he’s helping to make genomic medicine an
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...